Better Buy: Celgene vs. Gilead Sciences

Should you go with the biotech that's going away or the one that's bouncing back? That's pretty much the question for investors when it comes to deciding between Celgene (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD).

Celgene is probably only a few months away from being absorbed by Bristol-Myers Squibb (NYSE: BMY). Gilead appears to be making a comeback after several years of revenue and earnings declines. Which stock is now the better pick for investors?

Image source: Getty Images.

Continue reading

Source Fool.com